X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

ENDOCRINE

期刊標題檢索 ENDOCRINE 最新評論: Where can I see such detailed progress? (2024-06-04)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[ENDOCRINE]您好,您是該頁面的第 45088 位訪客。

期刊簡介
期刊名稱ENDOCRINE ENDOCRINE
LetPub Score
6.4
50 ratings
Rate

Reputation
7.5

Influence
5.3

Speed
6.9

期刊簡稱ENDOCRINE
ISSN1355-008X
E-ISSN1559-0100
h-index74
CiteScore
CiteScoreSJRSNIPCiteScore Rank
6.500.8440.941
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Endocrinology, Diabetes and Metabolism
Q279 / 244
Category: Medicine
Subcategory: Endocrinology
Q248 / 128

自引率 (2023-2024)6.70%自引率趨勢
掲載範囲
Well-established as a major journal in today’s rapidly advancing experimental and clinical research areas, Endocrine publishes original articles devoted to basic (including molecular, cellular and physiological studies), translational and clinical research in all the different fields of endocrinology and metabolism. Articles will be accepted based on peer-reviews, priority, and editorial decision. Invited reviews, mini-reviews and viewpoints on relevant pathophysiological and clinical topics, as well as Editorials on articles appearing in the Journal, are published. Unsolicited Editorials will be evaluated by the editorial team. Outcomes of scientific meetings, as well as guidelines and position statements, may be submitted. The Journal also considers special feature articles in the field of endocrine genetics and epigenetics, as well as articles devoted to novel methods and techniques in endocrinology.

Endocrine covers controversial, clinical endocrine issues. Meta-analyses on endocrine and metabolic topics are also accepted. Descriptions of single clinical cases and/or small patients studies are not published unless of exceptional interest. However, reports of novel imaging studies and endocrine side effects in single patients may be considered. Research letters and letters to the editor related or unrelated to recently published articles can be submitted.

Endocrine covers leading topics in endocrinology such as neuroendocrinology, pituitary and hypothalamic peptides, thyroid physiological and clinical aspects, bone and mineral metabolism and osteoporosis, obesity, lipid and energy metabolism and food intake control, insulin, Type 1 and Type 2 diabetes, hormones of male and female reproduction, adrenal diseases pediatric and geriatric endocrinology, endocrine hypertension and endocrine oncology.
官方網站https://www.springer.com/12020
在線稿件提交https://www.editorialmanager.com/endo
開放訪問No
出版商Springer US
主題領域ENDOCRINOLOGY & METABOLISM
出版國/地區UNITED STATES
發行頻率年12回刊行
創刊年1995
每年文章數342每年文章數趨勢
黃金OA百分比24.97%
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
ENDOCRINOLOGY & METABOLISMSCIEQ288/186
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1355-008X%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Average 1.5 Month(s)
競爭力 *來自作者的數據: About 75%
參考鏈接
相關期刊 【ENDOCRINE】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    NATURE REVIEWS DRUG DISCOVERYH-index: 289

    CiteScore: 137.40
    LANCETH-index: 700

    CiteScore: 148.10
    NEW ENGLAND JOURNAL OF MEDICINEH-index: 933

    CiteScore: 145.40
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    Nature Reviews Disease PrimersH-index: 48

    CiteScore: 76.70
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 93.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONH-index: 622

    CiteScore: 48.20
    World PsychiatryH-index: 70

    CiteScore: 64.10
    學科內最受檢索的期刊 頁面查看次數
    MEDICINE644492
    BIOMATERIALS595468
    Frontiers in Pharmacology499450
    BIOMEDICINE & PHARMACOTHERAPY498563
    JOURNAL OF ETHNOPHARMACOLOGY489001
    Journal of Materials Chemistry B476135
    Frontiers in Immunology460718
    COLLOIDS AND SURFACES B-BIOINTERFACES419440
    COMPUTERS IN BIOLOGY AND MEDICINE418735
    Frontiers in Oncology415246
  •  

    ENDOCRINE ENDOCRINE
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/7)
  [ENDOCRINE] 的評論撰寫評論
作者: 好起来了哦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-04 16:50:16 評論於
Where can I see such detailed progress?
(0) 讚! | 好起来了哦

作者: 书生永寿


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-30 18:42:48 評論於
1.23 peer review till now \(`Δ')/
(0) 讚! | 书生永寿

作者: 飞槐桑


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-30 15:15:35 評論於
I want to ask where to find the data requirements for the results? For example, the requirements for WB Full Membrane
(0) 讚! | 飞槐桑

作者: 飞槐桑


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-30 11:05:24 評論於
I would like to ask, where can I find the data requirements for the results? For example, the requirements for the WB full membrane
(0) 讚! | 飞槐桑

作者: 书生永寿


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-30 10:51:38 評論於
Alas, still no news, and reminders are useless
(0) 讚! | 书生永寿

作者: 俊衡酱大魔王


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-28 20:38:22 評論於
Review speed: 3.0 | Submission acceptance rate: 75.0 Research focus: Metabolic experience sharing Deadline: Submit on 9th March 2024 | Peer review on 11th March 2024 | Revision on 19th April 2024 | Final revision on 30th April 2024 | Acceptance on 29th May 2024
(0) 讚! | 俊衡酱大魔王

作者: Sampson Walton


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-20 09:41:58 評論於
Review speed: 6.0 | Submission acceptance rate: 75.0
Main research direction: Thyroid
Experience sharing: Submitted in December, received minor revision comments in March, accepted in April, published online at the end of April. The editor was very good, and the response to emails was very positive
(0) 讚! | Sampson Walton

作者: Alva Hornby


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-14 22:52:45 評論於
Hello, may I ask how long it will take to receive the proof after acceptance?
(0) 讚! | Alva Hornby

作者: Alva Hornby


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-14 11:07:27 評論於
How long does it take to receive the proof after it is submitted?
(0) 讚! | Alva Hornby

作者: 俊衡酱大魔王


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-12 13:11:24 評論於
After reviewing all the documents, I believe we can move forward with this project
(0) 讚! | 俊衡酱大魔王

作者: 俊衡酱大魔王


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-09 22:20:58 評論於
Thank you ?
(0) 讚! | 俊衡酱大魔王

作者: 青易来了


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-09 12:25:15 評論於
Hello, is the peer review status determined by the editorial department before sending for review or is it done externally?
(0) 讚! | 青易来了

作者: 蓉沼心霞


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-08 08:21:15 評論於
About 2 weeks
(0) 讚! | 蓉沼心霞

作者: 俊衡酱大魔王


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-07 19:46:44 評論於
How long will it take to hear from Xiaoxi after he returns?
(0) 讚! | 俊衡酱大魔王

作者: 蓉沼心霞


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-27 12:29:53 評論於
Review speed: 1.0 | Submission acceptance rate: 50.0
Research focus: Thyroid tumors
Experience sharing: Submitted on February 9th, revised on March 13th with only one reviewer. It took 2 weeks for revisions and was accepted in early April. The handling editor is the chief editor, very responsible and kind. After acceptance, they will send a proofreading version first and then ask if you want to pay for page charges. Worth submitting
(0) 讚! | 蓉沼心霞

作者: 御阪树人


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-22 19:14:34 評論於
In the submission system, there is no "original article" option under article type. What option did everyone choose for submission?
(0) 讚! | 御阪树人

作者: 御阪树人


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-22 16:31:03 評論於
What should I choose when submitting my article if the "original article" option is not available under article type?
(0) 讚! | 御阪树人

作者: 如来新曦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-14 23:11:30 評論於
How often are you online in general?
(0) 讚! | 如来新曦

作者: 俊衡酱大魔王


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-07 23:36:12 評論於
After the Technical check is the Peer review. The Peer review has been ongoing for one month. Has it been submitted for review?
(0) 讚! | 俊衡酱大魔王

作者: 俊衡酱大魔王


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-07 23:02:54 評論於
After Technical check is Peer review. Peer review has been going on for a month, is it ready for submission?
(0) 讚! | 俊衡酱大魔王

作者: 东风晨濡


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-02 17:55:32 評論於
Not invested yet
(0) 讚! | 东风晨濡

作者: 东风晨濡


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-31 18:38:08 評論於
Review speed: 2.0 | Submission hit rate: 50.0 Experience sharing: In the submission
(0) 讚! | 东风晨濡

作者: 宫古昌茂


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-21 09:31:37 評論於
After urging for submission, the magazine replied that it was still being edited. After waiting for half a month without any updates, I decided to withdraw my submission. I really can't agree with this slow speed
(0) 讚! | 宫古昌茂

作者: 书生永寿


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-13 18:26:56 評論於
I am also considering whether to change the system status uniformly
(0) 讚! | 书生永寿

作者: 东风晨濡


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-03-13 13:36:17 評論於
Review speed: 2.0 | Submission acceptance rate: 50.0 Experience sharing: In submission
(0) 讚! | 东风晨濡

首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/7)

開始撰寫 [ENDOCRINE] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*